Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0240086002
Search results
| Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
|---|---|---|---|---|---|---|---|---|---|
| Cancelled Post Market | 02357402 | ACTAVIS PHARMA COMPANY | ACT IRBESARTAN/HCT | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Cancelled Post Market | 02476444 | ANGITA PHARMA INC. | AG-IRBESARTAN HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Dormant | 02387654 | APOTEX INC | APO-IRBESARTAN/HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Dormant | 02447886 | AURO PHARMA INC | AURO-IRBESARTAN HCT | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Cancelled Post Market | 02373351 | AVANSTRA INC | AVA-IRBESARTAN/HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Marketed | 02241819 | SANOFI-AVENTIS CANADA INC | AVALIDE | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Cancelled Pre Market | 02372231 | DOMINION PHARMACAL | DOM-IRBESARTAN-HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Approved | 02404028 | JUBILANT GENERICS LIMITED | IRBESARTAN AND HYDROCHLOROTHIAZIDE | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Marketed | 02385325 | SIVEM PHARMACEUTICALS ULC | IRBESARTAN HCT | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Marketed | 02365170 | PRO DOC LIMITEE | IRBESARTAN-HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Cancelled Pre Market | 02434288 | ACTAVIS PHARMA COMPANY | IRBESARTAN/HCT | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Marketed | 02372894 | SANIS HEALTH INC | IRBESARTAN/HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Cancelled Post Market | 02418231 | JAMP PHARMA CORPORATION | JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Cancelled Post Market | 02393018 | MINT PHARMACEUTICALS INC | MINT-IRBESARTAN/HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Cancelled Pre Market | 02376881 | MYLAN PHARMACEUTICALS ULC | MYLAN-IRBESARTAN HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Cancelled Pre Market | 02368943 | TEVA CANADA LIMITED | NTP-IRBESARTAN/HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Approved | 02427214 | PENDOPHARM DIVISION OF PHARMASCIENCE INC | PENDO-IRBESARTAN-HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Marketed | 02328526 | PHARMASCIENCE INC | PMS-IRBESARTAN-HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Cancelled Post Market | 02363216 | RANBAXY PHARMACEUTICALS CANADA INC. | RAN-IRBESARTAN HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Marketed | 02337436 | SANDOZ CANADA INCORPORATED | SANDOZ IRBESARTAN HCT | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Marketed | 02330520 | TEVA CANADA LIMITED | TEVA-IRBESARTAN HCTZ | Human | Yes | Prescription | 2 | HYDROCHLOROTHIAZIDE | 12.5 MG |
| Cancelled Post Market | 02316021 | TEVA CANADA LIMITED | TEVA-IRBESARTAN/HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
| Cancelled Pre Market | 02427060 | VANC PHARMACEUTICALS INC | VAN-IRBESARTAN-HCTZ | Human | Yes | Prescription | 2 | IRBESARTAN | 300 MG |
Application information
Related information
Contact us
Version 4.0.2